Technological advancements in molecular diagnostics have led to the increased adoption of genetic testing services. These services include the interpretation of results, analysis, and counseling. In genetic testing, physicians recommend the type of test and service, and the genetic samples are analyzed in clinical laboratories. In DTC genetic testing, companies such as 23andMe market the service that they offer through media, emails, and television. There are several ethical concerns related to DTC genetic testing. Hence, many clinical laboratories and companies only conduct genetic testing when recommended by a physician.

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

Overview

DTC genetic testing

PART 05: Market landscape

Overview

Market size and forecast

Five forces analysis

PART 06: Segmentation by service

Diagnostic screening

Prenatal, newborn screening, and pre-implantation

diagnosis

Relationship testing

PART 07: Segmentation by channel

Overview

Direct sales

Clinical laboratories

Retail sales

PART 08: Segmentation by geography

Americas

EMEA

APAC

PART 09: Decision framework

PART 10: Drivers and challenges

Market drivers

Market challenges

PART 11: Market trends

Paradigm shift in business models

Next-generation sequencing and biochip for present and

future genetic diagnosis

Development of online applications to serve customer

needs

PART 12: Vendor landscape

Competitive landscape

PART 13: Key vendor analysis

23andMe

LabCorp

Myriad Genetics

Quest Diagnostics

Other prominent vendors

PART 14: Appendix

List of abbreviations

PART 15: Explore Technavio